These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2868070)

  • 1. Human cerebrospinal fluid somatostatin in neurologic disease.
    Beal MF; Mazurek MF; Black PM; Martin JB
    J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
    Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
    Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin-like immunoreactivity (NTLI) concentration in the cerebrospinal fluid of children and its alteration in a febrile aseptic meningitis.
    Muraki K; Nishi Y; Okahata H; Arai M; Yamada H; Fujita S; Miyachi Y; Ueda K; Yamawaki S; Yajima H
    Life Sci; 1987 Apr; 40(14):1365-70. PubMed ID: 3561155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man.
    Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A
    Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for somatostatin precursors in human stomach, placenta, and amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):372-6. PubMed ID: 6114109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
    Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
    Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term follow-up study of cerebrospinal fluid somatostatin in delirium.
    Koponen HJ; Leinonen E; Lepola U; Riekkinen PJ
    Acta Psychiatr Scand; 1994 May; 89(5):329-34. PubMed ID: 7915078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF somatostatin increase in patients with early parkinsonian syndrome.
    Espino A; Calopa M; Ambrosio S; Ortolà J; Peres J; Navarro MA
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):189-96. PubMed ID: 8527003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement, characterization, and source of somatostatin-like immunoreactivity in human amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Invest; 1979 Sep; 64(3):737-42. PubMed ID: 468988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
    Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
    J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography.
    Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Imura H
    Diabetes; 1981 Jun; 30(6):471-4. PubMed ID: 6112180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF somatostatin-like immunoreactivity in dementia.
    Beal MF; Growdon JH; Mazurek MF; Martin JB
    Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin in human cerebrospinal fluid.
    Patel Y; Rao K; Reichlin S
    N Engl J Med; 1977 Mar; 296(10):529-33. PubMed ID: 836537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
    Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
    Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease.
    Cramer H; Rösler N; Rissler K; Gagnieu MC; Renaud B
    Neuropeptides; 1988 Oct; 12(3):119-24. PubMed ID: 2468107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients.
    Kohler J; Schröter E; Cramer H
    Arch Psychiatr Nervenkr (1970); 1982; 231(6):503-8. PubMed ID: 6127989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin-like immunoreactivity (SLI) in cisternal cerebrospinal fluid of rats kindled by pentylenetetrazol.
    Pitkänen A; Jolkkonen J; Riekkinen PJ
    Brain Res; 1987 Jul; 416(1):180-2. PubMed ID: 2887246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up.
    Koponen H; Reinikainen K; Riekkinen PJ
    Psychol Med; 1990 Aug; 20(3):501-5. PubMed ID: 1978369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low somatostatin content in cerebrospinal fluid in multiple sclerosis. An indicator of disease activity?
    Sørensen KV; Christensen SE; Dupont E; Hansen AP; Pedersen E; Orskov H
    Acta Neurol Scand; 1980 Mar; 61(3):186-91. PubMed ID: 6104886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.